FDA Drug recall D-104-2013
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San J…
- FDA Drug
- Class II
- terminated
- Published 2013-01-02
On 2013-01-02 the FDA classified a Class II recall of Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San J… by Alara Pharmaceutical, citing subpotent; 15 month stability.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-104-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-10-29 |
| Published | 2013-01-02 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Alara Pharmaceutical |
| Distribution | US |
Product
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR
Reason
Subpotent; 15 month stability
Identifiers
| code_info | 11T7011A, Exp. Date: 12/2012 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-104-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.